| Genetics and epigenetics of liver cancer C Ozen, G Yildiz, AT Dagcan, D Cevik, A Ors, U Keles, H Topel, M Ozturk New biotechnology 30 (4), 381-384, 2013 | 118 | 2013 |
| Potential Applications of NRF2 Modulators in Cancer Therapy E Panieri, A Buha, P Telkoparan-Akillilar, D Cevik, D Kouretas, ... Antioxidants 9 (193), 3, 2020 | 113 | 2020 |
| Common telomerase reverse transcriptase promoter mutations in hepatocellular carcinomas from different geographical locations D Cevik, G Yildiz, M Ozturk World Journal of Gastroenterology: WJG 21 (1), 311, 2015 | 67 | 2015 |
| Therapeutic targeting of the NRF2 signaling pathway in cancer P Telkoparan-Akillilar, E Panieri, D Cevik, S Suzen, L Saso Molecules 26 (5), 1417, 2021 | 59 | 2021 |
| Identification of miR-17, miR-21, miR-27a, miR-106b and miR-222 as endoplasmic reticulum stress-related potential biomarkers in circulation of patients with atherosclerosis P Telkoparan-Akillilar, D Cevik Molecular Biology Reports 48, 3503-3513, 2021 | 10 | 2021 |
| Expression patterns of miR-34a, miR-125b, miR-221 and antioxidant gene NRF2 in plasma samples of patients with atherosclerosis P Telkoparan-Akillilar, D Cevik, A Yilmaz Journal of Biosciences 47 (1), 1, 2022 | 3 | 2022 |
| The Applications of Next-generation Sequencing (NGS) in Drug Development for Cancer Therapy P Telkoparan-Akillilar, D Cevik Current Analytical Chemistry 17 (8), 1074-1081, 2021 | 1 | 2021 |
| Identification of differentially expressed miRNAs and mRNAs associated with the regulation of breast cancer via in silico and in vitro methods P Telkoparan-Akillilar, D Cevik Cytotechnology 75 (5), 363-379, 2023 | | 2023 |
| Temel Tıp Bilimlerinde Güncel Konular B ORHAN, ÖZ Mehmet, D ÇEVİK, ZM ALTAŞ, S YILDIZ Livre de Lyon, 2023 | | 2023 |
| Reactivation of telomerase reverse transcriptase gene in liver cancer D Çevik PQDT-Global, 2014 | | 2014 |
